Penn Medicine studies unlock new insights into gene therapy upenn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from upenn.edu Daily Mail and Mail on Sunday newspapers.
- Precision to present late breaker PBGENE-HBV data at The Liver Meeting of AASLD in November 2023
- Hosted R&D Day highlighting exclusive focus on in vivo gene editing pipeline
- Expanded.
AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
PHILADELPHIA, Oct. 30, 2023 (GLOBE NEWSWIRE) Passage Bio, Inc. (NASDAQ:PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders,
PHILADELPHIA, Oct. 30, 2023 (GLOBE NEWSWIRE) Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference on Monday, November 6, 2023 at 2:30 p.m. ET. A live webcast of the event will be available on